Neonatal helper-dependent adenoviral vector gene therapy mediates correction of hemophilia A and tolerance to human factor VIII.

Source:http://linkedlifedata.com/resource/pubmed/id/21245323

Proc. Natl. Acad. Sci. U.S.A. 2011 Feb 1 108 5 2082-7

Download in:

View as

Triples

General Info

PMID
21245323